Filing
Spy
Filing
Spy
Home
About
AKBA
Akebia Therapeutics Inc
Biopharmaceutical company
CUSIP: 00972D105
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2020 Q3
3 of 11 quarters
Total Value
$14.20M
Total Shares
5.66M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Abrams Capital Management
$14.20M
5.66M
0.4%
Unchanged
Abrams Capital Management
$14.20M
5.66M shares
Unchanged
AKBA — Akebia Therapeutics Inc - FilingSpy